Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $1.02 Million - $1.15 Million
5,330 Added 99.96%
10,662 $2.26 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $8,256 - $9,075
44 Added 0.83%
5,332 $1.03 Million
Q1 2023

May 09, 2023

SELL
$127.59 - $203.08 $771,536 - $1.23 Million
-6,047 Reduced 53.35%
5,288 $1.07 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $7,042 - $8,350
-60 Reduced 0.53%
11,335 $1.46 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $119,713 - $159,397
-885 Reduced 7.21%
11,395 $1.56 Million
Q2 2022

Aug 16, 2022

SELL
$108.81 - $179.33 $110,986 - $182,916
-1,020 Reduced 7.67%
12,280 $2.17 Million
Q1 2022

May 17, 2022

SELL
$119.61 - $157.85 $81,932 - $108,127
-685 Reduced 4.9%
13,300 $1.92 Million
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $958,070 - $1.28 Million
6,720 Added 92.5%
13,985 $2.16 Million
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $252,136 - $300,581
1,770 Added 32.21%
7,265 $1.23 Million
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $21,612 - $25,776
160 Added 3.0%
5,495 $868,000
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $77,005 - $106,848
560 Added 11.73%
5,335 $741,000
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $786,108 - $1.01 Million
4,775 New
4,775 $836,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.